Diphenhydramine Hydrochloride 25mg Tablet
FDA Label NDC 70692-148

11 label sections · Submitted to the FDA by Strive Pharmaceuticals Inc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Strive Pharmaceuticals Inc for the product Diphenhydramine Hydrochloride 25mg (NDC 70692-148). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, active ingredient (in each tablet), purpose, uses, warnings, otc - keep out of reach of children, directions, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient (In Each Tablet)

Diphenhydramine HCl 25 mg

Uses

temporarily relieves these symptoms due to hay fever or upper respiratory allergies:
      • runny nose             • sneezing
      • itchy, watery eyes  • itching of the nose or throat
temporarily relieves these symptoms due to the common cold:
      • runny nose             • sneezing

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.
Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.

Inactive Ingredients

croscarmellose sodium, dicalcium phosphate, D&C red #27, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, silicon dioxide, talc, titanium dioxide

Questions Or Comments?

1-888-577-8033 Monday-Friday 8am-4pm EST

Packaging

Strive-148-1 (70692148 3)

Strive-148-1 (70692148 3)

Strive-148-2 (70692148 4)

Strive-148-2 (70692148 4)

* Please review the disclaimer below.